Search research articles
Contact Us
Filters
Showing results (1-10 of 383) with videos related to
Page
of 39
Sort By:
Topics in HIV Medicine : a Publication of the International AIDS Society, USA
|
August 18, 2004
Substance use of disorders in HIV-infected patients: impact and new treatment strategies
David A Fiellin
Addiction (Abingdon, England)
|
March 26, 2003
Methadone syrup injection in Australia: a sentinel finding?
David A Fiellin
Journal of Addiction Medicine
|
July 20, 2011
The first three years of buprenorphine in the United States: experience to date and future directions
David A Fiellin
Journal of Addiction Medicine
|
October 2, 2024
Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction
David A Fiellin
Journal of Addiction Medicine
|
September 27, 2022
Buprenorphine Initiation in the Era of High-potency Synthetic Opioids: A Call for Community-based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder
David A Fiellin
American Family Physician
|
May 25, 2006
Buprenorphine: effective treatment of opioid addiction starts in the office
David A Fiellin
JAMA
|
November 6, 2008
Treatment of adolescent opioid dependence: no quick fix
David A Fiellin
Annals of Internal Medicine
|
November 22, 2017
More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic
Jeanette M Tetrault, David A Fiellin
Journal of Addiction Medicine
|
May 18, 2021
A Case of Kratom Use: Implications for Managing Addiction and Addressing Comorbidity in Overdose Survivors, and for the Education of Clinicians Who Are Not Addiction Specialists
Joseph H Donroe, David A Fiellin
The American Journal on Addictions
|
June 19, 2004
Buprenorphine for office-based practice: consensus conference overview
Thomas R Kosten, David A Fiellin,
Page
of 39
Search research articles
Search
Showing results (1-10 of 383) with videos related to
Sort By:
Page
of 39
Topics in HIV Medicine : a Publication of the International AIDS Society, USA
|
August 18, 2004
Substance use of disorders in HIV-infected patients: impact and new treatment strategies
David A Fiellin
Addiction (Abingdon, England)
|
March 26, 2003
Methadone syrup injection in Australia: a sentinel finding?
David A Fiellin
Journal of Addiction Medicine
|
July 20, 2011
The first three years of buprenorphine in the United States: experience to date and future directions
David A Fiellin
Journal of Addiction Medicine
|
October 2, 2024
Treatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction
David A Fiellin
Journal of Addiction Medicine
|
September 27, 2022
Buprenorphine Initiation in the Era of High-potency Synthetic Opioids: A Call for Community-based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder
David A Fiellin
American Family Physician
|
May 25, 2006
Buprenorphine: effective treatment of opioid addiction starts in the office
David A Fiellin
JAMA
|
November 6, 2008
Treatment of adolescent opioid dependence: no quick fix
David A Fiellin
Annals of Internal Medicine
|
November 22, 2017
More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic
Jeanette M Tetrault, David A Fiellin
Journal of Addiction Medicine
|
May 18, 2021
A Case of Kratom Use: Implications for Managing Addiction and Addressing Comorbidity in Overdose Survivors, and for the Education of Clinicians Who Are Not Addiction Specialists
Joseph H Donroe, David A Fiellin
The American Journal on Addictions
|
June 19, 2004
Buprenorphine for office-based practice: consensus conference overview
Thomas R Kosten, David A Fiellin,
Page
of 39